DEFTA Partners logo

DEFTA Partners

North America, California, United States, San Francisco

Description

DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage

Investor Profile

DEFTA Partners has made 25 investments, with 0 in the past 12 months and 16% as lead.

Stage Focus

  • Series A (52%)
  • Series Unknown (20%)
  • Series B (20%)
  • Series D (4%)
  • Seed (4%)

Country Focus

  • United States (92%)
  • Israel (8%)

Industry Focus

  • Medical
  • Biotechnology
  • Health Care
  • Software
  • Therapeutics
  • Mobile
  • Video
  • Artificial Intelligence (Ai)
  • Enterprise Software
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DEFTA Partners frequently co-invest with?

Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 3
GVA LaunchGurus Fund 1 L.P.
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 2
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 2
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 3
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
CE Ventures (CEIIF)
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Walden Venture Capital
North America, California, United States, San Francisco
Co-Investments: 3
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 3
AltaIR Capital
North America, California, United States, San Francisco
Co-Investments: 3

Which angels does DEFTA Partners often collaborate with?

Shmuel Cabilly
Asia, HaMerkaz, Israel, Rehovot
Shared Deals: 1

What are some of recent deals done by DEFTA Partners?

Endogena

San Francisco, California, United States

Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.

BiotechnologyMedicalTherapeutics
Series ADec 13, 2021
Amount Raised: $21,000,000
DiA Imaging Analysis

Be'er Sheva, HaDarom, Israel

DiA Imaging Analysis provides advanced AI-based ultrasound analysis smarter and accessible.

Artificial Intelligence (AI)Health CareMedicalSoftware
Series UnknownAug 24, 2021
Amount Raised: $14,000,000
Endogena

San Francisco, California, United States

Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.

BiotechnologyMedicalTherapeutics
Series AJan 28, 2021
Amount Raised: $8,000,000
Aegle Therapeutics

Miami, Florida, United States

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

BiotechnologyClinical TrialsTherapeutics
Series ASep 29, 2020
Amount Raised: $6,500,000
InformAI

Houston, Texas, United States

InformAI is an AI company that develops artificial intelligence and deep learning algorithms for healthcare applications.

Artificial Intelligence (AI)Health CareImage RecognitionInsurTechMachine LearningMedicalSoftware
SeedJun 26, 2020
Amount Raised: $1,800,000
TARA Biosystems

New York, New York, United States

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

BiotechnologyMedical
Series AJun 23, 2020
Amount Raised: $10,000,000
1World Online

Redwood City, California, United States

1World Online is a A.I.-powered platform that unifies the values of data and advertising into an all-in-one engagement driven model.

AnalyticsBig DataBlockchainEnterprise SoftwareMarket ResearchMobileSoftware
Series AFeb 21, 2020
Amount Raised: $8,475,104
Aegle Therapeutics

Miami, Florida, United States

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

BiotechnologyClinical TrialsTherapeutics
Series AJan 9, 2020
Amount Raised: $4,000,000
Actuate Therapeutics

Fort Worth, Texas, United States

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

BiotechnologyMedicalPharmaceutical
Series BNov 12, 2019
Amount Raised: $6,500,000
BioEclipse Therapeutics

San Francisco, California, United States

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.

BiotechnologyHealth CareOncologyTherapeutics
Series AJun 24, 2019
Amount Raised: $7,700,000